Project Number 3U01AG046161-03S1 Agency/Funding Organization NIA Funding Year 2016 View Full Project Details for DISCOVERY OF NOVEL PROTEOMIC TARGETS FOR TREATMENT OF ALZHEIMER'S DISEASE Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 2. Identification and Validation of Novel Targets Category G. Consortia and Public Private Partnerships 2. Public Private Partnership Researcher and Organization Principal Investigator LEVEY, ALLAN I Principal Investigator First Name ALLAN Principal Investigator Last Name LEVEY Awardee Organization EMORY UNIVERSITY Awardee State Georgia Contact PI Country United States Project Detail Funding Opportunity Announcement RFA-AG-13-013: Interdisciplinary Approach to Identification and Validation of Novel Therapeutic Targets for Alzheimer's Disease (R01) FY Overall Cost $160,872 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official REFOLO, LORENZO Special Initiative Accelerating Medicines Partnership - Alzheimer's Disease (AMP-AD): Target Discovery and Preclinical Validation Project Related Resources Repository [AMP-AD Knowledge Portal] Discovery of Novel Proteomic Targets for Treatment of Alzheimer's Disease
